My patient is taking a statin and is scheduled for surgery
Authors:
Jan Piťha
Published in:
Čas. Lék. čes. 2024; 163: 309-313
Category:
Review Article
Overview
Statins rank among the most useful drug groups with convincing data from clinical trials, especially in patients at very high risk of developing or recurring cardiovascular events of atherosclerotic origin. As with all effective drugs, side effects are described also for statins, but these effects are rare. Nevertheless, because statins are used by many individuals for a long time periods, these effects could be observed. The main discussed ones include myopathy, hepatopathy, decreased renal function and higher incidence of diabetes mellitus. Another area of recent discussions is the possibility of untoward effects of statins during extensive surgical procedures, when it is considered their discontinuation.
However, the vast majority of available data demonstrated that statins are safe or even beneficial in terms of surgical procedures complications. Therefore, discontinuation of these drugs before surgery is not recommended in majority of individuals. Nevertheless, in certain risk groups statins could cause complications; these include patients with impaired renal function exposed to loading dose of statins before surgery. However, the presumption that the most serious complication of surgery might be unnecessary discontinuation of statins is still valid.
Keywords:
statins, side effects, surgery
Sources
- Grundy SM, Stone NJ, Bailey AL, et al. AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019; 139: e1046–e1081.
- Zheng Z, Jayaram R, Jiang L et al. Perioperative rosuvastatin in cardiac surgery. N Engl J Med 2016; 374: 1744-1753.
- de Zeeuw D, Anzalone DA, Cain VA et al. Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trial. Lancet Diabetes Endocrinol 2015; 3: 181–190.
- Billings FT 4th, Hendricks PA, Schildcrout JS et al. High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial. JAMA 2016; 315: 877–888.
- Schetz M, Oudemans-Van Straaten H. Statins do not prevent cardiac surgery-associated AKI: is ubiquinone the missing link? Intensive Care Med 2016; 42: 1464–1466.
- Honore PM, Jacobs R, Hendrckx I et al. Statins barely touch the heart but bite the kidneys after cardiac surgery. Coenzyme Q10 deficiency in the dock? Ann Transl Med 2016; 4 (Suppl. 1): S48.
- Durazzo AES, Machado FS, Ikeoka DT et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 2004; 39: 967–975.
- Schouten O, Boersma E, Hoeks SE et al. Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med 2009; 361: 980–989.
- Lilja F, Wanhainen A, Mani K. Statin therapy after elective abdominal aortic aneurysm repair improves long-term survival. Br J Surg 2024; 111: znad383.
- Lee Y, Im S, Kang Y et al. Impact of perioperative high-intensity statin treatment on the occurrence of postoperative atrial fibrillation after coronary artery bypass grafting: a meta-analysis. Acute Crit Care 2024; 39: 507–516.
- Lindenauer PK, Pekow P, Wang K et al. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA 2004; 291: 2092–2099.
- Jeppsson A, Rocca B, Hansson et al. 2024 EACTS guidelines on perioperative medication in adult cardiac surgery. Eur J Cardiothorac Surg 2024; 67: ezae355.
- Ma B, Sun J, Diao S, Zheng B et al. Effects of perioperative statins on patient outcomes after noncardiac surgery: a meta-analysis. Ann Med 2018; 50: 402–409.
- Pourlotfi A, Ahl R, Sjolin G et al. Statin therapy and postoperative short-term mortality after rectal cancer surgery. Colorectal Dis 2021; 23: 875–881.
- Suzumura EA, Ribeiro RA, Kawano-Dourado L et al. Effects of perioperative statin use on cardiovascular complications in patients submitted to non-cardiac surgery: protocol for a systematic review, meta-analysis, and trial sequential analysis. Syst Rev 2017; 6: 116.
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistArticle was published in
Journal of Czech Physicians

Most read in this issue
- My patient is taking a statin and is scheduled for surgery
- The decision-making on cost-inefficient care
- Harm reduction and tobacco smoking
- Efficiency of health care in the Czech Republic in international comparison 2010–2021